𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy with cisplatin and paclitaxel in patients with locally advanced, recurrent or metastatic oesophageal cancer

✍ Scribed by Petrasch, S; Welt, A; Reinacher, A; Graeven, U; König, M; Schmiegel, W

Book ID
109838585
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
627 KB
Volume
78
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial combining paclitaxel with
Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma
✍ Chiun Hsu; Chiun-Sheng Huang; Tsu-Yi Chao; Yen-Shen Lu; Ching-Fang Bu; Mary M. C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## BACKGROUND Both paclitaxel and cisplatin are active as second‐line chemotherapy for patients with breast carcinoma. A synergistic cytotoxicity of these two drugs has been demonstrated in vitro. This study sought to determine the efficacy of combining these two drugs in the treatment

Chemotherapy for patients with locally a
Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma
✍ Eric Voog; Pierre Biron; Jean-Pierre Martin; Jean-Yves Blay 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## BACKGROUND. Merkel cell carcinoma (MCC) is a highly malignant skin neoplasm. Regional lymph node and distant metastasis occur in 20 -52% of patients. The role of chemotherapy in the treatment of patients with this rare tumor is unclear. METHODS. An exhaustive analysis of the literature (1980